ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 46,483 | 47,286 | 48,164 | 44,764 | 36,628 |
| Cost of Goods | 20,693 | 20,446 | 21,078 | 21,122 | 16,386 |
| Gross Profit | 25,790 | 26,840 | 27,086 | 23,642 | 20,242 |
| Operating Expenses | 19,946 | 19,907 | 17,833 | 16,770 | 16,003 |
| Operating Income | 6,537 | 7,379 | 9,331 | 6,994 | 4,625 |
| Interest Expense | 3,634 | 3,026 | 3,052 | 3,025 | 2,932 |
| Other Income | -61 | -3 | 95 | -19 | -18 |
| Pre-tax Income | 2,842 | 4,350 | 6,374 | 3,950 | 1,675 |
| Income Tax | 592 | 13,979 | 1,654 | 1,269 | 523 |
| Net Income Continuous | 2,250 | -9,629 | 4,720 | 2,681 | 1,152 |
| Net Income | $2,250 | $-9,629 | $4,720 | $2,681 | $1,152 |
| EPS Basic Total Ops | 0.19 | -0.83 | 0.41 | 0.23 | 0.10 |
| EPS Basic Continuous Ops | 0.19 | -0.83 | 0.41 | 0.23 | 0.10 |
| EPS Diluted Total Ops | 0.19 | -0.82 | 0.40 | 0.23 | 0.10 |
| EPS Diluted Continuous Ops | 0.19 | -0.83 | 0.40 | 0.23 | 0.10 |
| EBITDA(a) | $14,732 | $14,401 | $16,430 | $14,095 | $11,331 |